Alejandro Cremades & Lynn Seely , DealMakers: Entrepreneur | Startups | Venture Capital

Lynn Seely On Raising $1 Billion To Redefine Care For Women And Men

27 Oct 2020 • 34 min • EN

Lynn Seely started Myovant Sciences which delivers innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market. The company has raised $1 billion from investors such as Danippon Sumitomo Pharma. Myovant Sciences was one of the largest biopharma IPOs in 2016.

From "DealMakers: Entrepreneur | Startups | Venture Capital"